Schneider Children's Medical Center of Israel
Institute of Gastroenterology, Nutrition and Liver Diseases
Dror Shouval is a Professor of Pediatrics at Tel Aviv University. He is the Director of the IBD Center at the Institute of Gastroenterology, Nutrition and Liver Diseases at Schneider Children's Medical Center of Israel, and heads a Pediatric IBD research lab located at the hospital. He is also member of the Porto IBD group of ESPGHAN (and heads the research committee) and is a member of the Pediatric ECCO committee. Prof. Shouval completed a Pediatric Residency at Schneider Children's Medical Center, and later a Pediatric Gastroenterology Fellowship and an Advanced IBD Fellowship at Boston Children's Hospital. In addition, he obtained a Mater's Degree in Clinical and Translational Investigation from Harvard Medical School. Prof. Shouval has co-authored >90 manuscripts published in high-impact journals. His research focuses on understanding the causes of IBD, with a focus on monogenic disorders and pathways of mucosal homeostasis. In addition, he is interested in studies assessing clinical outcomes of pediatric IBD. patients, and has been involved in national and international IBD guidelines preparation.

Presenter of 2 Presentations

EARLY ONSET IBD (ID 1522)

Session Type
AHP Course
Date
Wed, 17.05.2023
Session Time
10:00 - 11:50
Room
Hall K2
Lecture Time
11:00 - 11:25

G-O078 - MUCOSAL CLOCK AND INFLAMMATION REGULATORY GENES ARE DISRUPTED IN TREATMENT NAÏVE PEDIATRIC PATIENTS WITH ULCERATIVE COLITIS (ID 670)

Session Type
Gastroenterology
Date
Fri, 19.05.2023
Session Time
12:00 - 13:00
Room
Hall C
Lecture Time
12:45 - 12:54

Abstract

Objectives and Study

The human circadian clock is present in all cells. It includes the CLOCK and BMAL1 genes which heterodimerize to mediate transcription of many genes, including their negative regulators: PERIODs (PERs) and CRYPTOCHROMEs (CRYs). We have shown that patients with active ulcerative colitis (UC) display misalignment of the molecular clock that reverts to normal following effective treatment. Several circadian clock genes also function as anti-inflammatory regulators. For example, RORα, PPARα and PPARγ positively regulate the expression of both the clock mechanism and that of IkB, the NFkB suppressor. Similarly, PCG1α​​​​​​​ induces transcription of IL10. Our aim was to characterize the expression of these clock genes and regulators and determine their correlations in UC patients.

Methods

Using whole transcriptome RNA sequencing from the IBD Transcriptome and Metatranscriptome Meta-Analysis platform(TaMMA IBD), we compared rectal biopsy gene expression levels and correlations of AMPK, BMAL1, CLOCK, CRY1, CRY2, PER1, PER2, PCG1α, PPARα, PPARγ, REV-ERBα, RORα, RORγ and SIRT1 in 206 treatment naïve pediatric UC patients (age 12.9±3.2; 54% male) and 20 healthy controls (age 13.9±3.3; 45% male).

Results

Core clock genes, BMAL (p<0.0001), CLOCK (p<0.01) and CRY1 (p<0.0001), and the anti-inflammatory regulatory gene RORα (p<0.0001) were upregulated in patients compared to controls. In contrast, expression of other anti-inflammatory regulatory genes, PCG1α (p<0.0001), PPARα (p<0.01), PPARγ (p<0.0001) and RORγ (p<0.0001) were decreased in patients. Clock gene expression of healthy controls showed discordant correlations compared to UC patients, e.g., BMAL/REV-ERBα and PPARγ/REV-ERBα correlations were inverted between controls and patients (r=-0.44 vs. r=0.13 and r =-0.4 vs. r=0.3, respectively).

Conclusions

Core clock gene expression was disrupted, and anti-inflammatory regulatory gene expression was decreased in patients with active UC. The discordant correlations in UC patients highlight clock disruption in active inflammation. Since these clock regulators also ameliorate inflammation, their reduced expression may explain not only clock dysregulation but also increased tissue inflammation.

fig1_jpg.jpg

Hide